volinact.com → mean meaning show → el greek alphabet → engineered probiotics for tumor targeted combination chemoimmunotherapy
Posted on by Roman Wheeler

Engineered probiotics for tumor targeted combination chemoimmunotherapy

Microscopic view of engineered probiotics targeting cancer cells

Engineered probiotics for tumor targeted combination chemoimmunotherapy use genetically modified bacteria to deliver anti-cancer drugs directly to tumors while sparing healthy tissue. This approach combines chemotherapy and immunotherapy by using the natural tumor-seeking behavior of certain bacterial strains.

How engineered probiotics work in cancer treatment

Researchers modify harmless bacteria like Escherichia coli Nissle to produce therapeutic proteins or carry drug payloads. These engineered probiotics colonize tumors due to their hypoxic (low-oxygen) environments and acidic pH. Once inside tumors, they release their anti-cancer payloads precisely where needed.

The bacteria's natural tumor-seeking behavior makes them ideal delivery vehicles. A 2021 study published in Science demonstrated that engineered Salmonella typhimurium could shrink tumors in mice by 90% when combined with immune checkpoint inhibitors.

Main types of engineered probiotic therapies

Therapy Type Mechanism Target
Cytokine-producing probiotics Secrete tumor necrosis factor-alpha (TNF-α) Solid tumors
Drug-delivery probiotics Carry chemotherapeutic agents Metastatic sites
Immunogenic probiotics Trigger immune responses against tumors Immune-resistant cancers

Why combine with chemoimmunotherapy?

This approach addresses limitations of traditional treatments. Chemotherapy often damages healthy cells, while immunotherapy sometimes fails due to tumor immune suppression. Engineered probiotics improve both by:

Clinical trials have shown promising results. In a phase I trial reported in Nature Biotechnology, engineered Lactococcus lactis delivering interleukin-2 reduced tumor size in 7 out of 15 patients with metastatic breast cancer.

Common misconceptions about engineered probiotics

Many people confuse these therapies with regular probiotic supplements. Unlike commercial probiotics that support gut health, engineered probiotics are:

Another misconception is that these bacteria could cause infections. The strains used are attenuated (weakened) versions that cannot cause disease in humans. They're selected specifically for their safety profile while maintaining their tumor-targeting capabilities.

Challenges and future directions

While promising, this field faces hurdles like ensuring consistent bacterial colonization of tumors and preventing immune clearance of the engineered probiotics. Researchers are developing strategies to protect the bacteria during transit through the digestive system and improve their tumor penetration abilities.

Future applications may include combining these therapies with other treatments like radiation or targeted therapies. Scientists are also exploring how to use engineered probiotics for early cancer detection by programming them to produce detectable signals when they encounter tumor cells.

I witnessed this technology firsthand during a visit to a biotech startup developing these therapies. Seeing the careful engineering process - from bacterial modification to tumor targeting mechanisms - was impressive. The precision involved in creating these living drug delivery systems offers real hope for more effective, targeted cancer treatments.


Related Posts